These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 23144766
1. Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens. Kawabe Y, Hayashida Y, Numata K, Harada S, Hayashida Y, Ito A, Kamihira M. PLoS One; 2012; 7(10):e48512. PubMed ID: 23144766 [Abstract] [Full Text] [Related]
2. Immunological and Symptomatic Effects of Oral Intake of Transgenic Rice Containing 7 Linked Major T-Cell Epitopes from Japanese Cedar Pollen Allergens. Endo T, Asaka D, Nakayama T, Saito S, Kodama H, Mitsuyoshi R, Takaishi S, Sugimoto N, Omae S, Takagi H, Wakasa Y, Ozawa K, Takano M, Takaiwa F, Kojima H, Saito S. Int Arch Allergy Immunol; 2021; 182(2):109-119. PubMed ID: 32854094 [Abstract] [Full Text] [Related]
3. Approaches to immunotherapies for Japanese cedar pollinosis. Sakaguchi M, Hirahara K, Fujimura T, Toda M. Auris Nasus Larynx; 2011 Aug; 38(4):431-8. PubMed ID: 21227607 [Abstract] [Full Text] [Related]
4. Nisin-induced expression of recombinant T cell epitopes of major Japanese cedar pollen allergens in Lactococcus lactis. Van Hoang V, Ochi T, Kurata K, Arita Y, Ogasahara Y, Enomoto K. Appl Microbiol Biotechnol; 2018 Jan; 102(1):261-268. PubMed ID: 29094185 [Abstract] [Full Text] [Related]
5. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis. Sone T, Morikubo K, Miyahara M, Komiyama N, Shimizu K, Tsunoo H, Kino K. J Immunol; 1998 Jul 01; 161(1):448-57. PubMed ID: 9647255 [Abstract] [Full Text] [Related]
6. Effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, on an experimental allergic rhinitis model in B10.S mice. Tsunematsu M, Yamaji T, Kozutsumi D, Murakami R, Kimura S, Kino K. Allergol Int; 2007 Dec 01; 56(4):465-72. PubMed ID: 17965586 [Abstract] [Full Text] [Related]
7. Development of a rice-based peptide vaccine for Japanese cedar and cypress pollen allergies. Takaiwa F, Yang L. Transgenic Res; 2014 Aug 01; 23(4):573-84. PubMed ID: 24638148 [Abstract] [Full Text] [Related]
8. Cross-reactivity between major IgE core epitopes on Cry j 2 allergen of Japanese cedar pollen and relevant sequences on Cha o 2 allergen of Japanese cypress pollen. Miyaji K, Okamoto N, Saito A, Yasueda H, Takase Y, Shimakura H, Saito S, Sakaguchi M. Allergol Int; 2016 Jul 01; 65(3):286-92. PubMed ID: 26916996 [Abstract] [Full Text] [Related]
9. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT. Osada T, Tanaka Y, Yamada A, Sasaki E, Utsugi T. Allergol Int; 2018 Oct 01; 67(4):467-474. PubMed ID: 29525489 [Abstract] [Full Text] [Related]
10. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine. Hiroi T, Takaiwa F. Curr Opin Allergy Clin Immunol; 2006 Dec 01; 6(6):455-60. PubMed ID: 17088651 [Abstract] [Full Text] [Related]
11. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens. Hirahara K, Tatsuta T, Takatori T, Ohtsuki M, Kirinaka H, Kawaguchi J, Serizawa N, Taniguchi Y, Saito S, Sakaguchi M, Inouye S, Shiraishi A. J Allergy Clin Immunol; 2001 Jul 01; 108(1):94-100. PubMed ID: 11447388 [Abstract] [Full Text] [Related]
12. T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens. Takaishi S, Saito S, Endo T, Asaka D, Wakasa Y, Takagi H, Ozawa K, Takaiwa F, Otori N, Kojima H. Immunology; 2019 Oct 01; 158(2):94-103. PubMed ID: 31323138 [Abstract] [Full Text] [Related]
13. Analysis of conformational and sequential IgE epitopes on the major allergen Cry j 2 of Japanese cedar (Cryptomeria japonica) pollen in humans by using monoclonal antibodies for Cry j 2. Miyaji K, Yurimoto T, Saito A, Yasueda H, Takase Y, Shimakura H, Okamoto N, Kiuchi A, Saito S, Sakaguchi M. J Clin Immunol; 2013 Jul 01; 33(5):977-83. PubMed ID: 23504147 [Abstract] [Full Text] [Related]
14. Identification of peptides containing T-cell epitopes of Japanese cedar (Cryptomeria japonica) pollen allergen (Cry j 1) in dogs. Masuda K, Sakaguchi M, Saito S, Yasueda H, Iwabuchi S, Tsukui T, Hayashi N, Nakao Y, Kurata K, Maeda S, Ohno K, Tsujimoto H. Vet Immunol Immunopathol; 2004 Nov 01; 102(1-2):45-52. PubMed ID: 15451614 [Abstract] [Full Text] [Related]
15. Transcutaneous Peptide Immunotherapy of Japanese Cedar Pollinosis Using Solid-in-Oil Nanodispersion Technology. Kitaoka M, Shin Y, Kamiya N, Kawabe Y, Kamihira M, Goto M. AAPS PharmSciTech; 2015 Dec 01; 16(6):1418-24. PubMed ID: 25986596 [Abstract] [Full Text] [Related]
16. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis. Wakasa Y, Takagi H, Hirose S, Yang L, Saeki M, Nishimura T, Kaminuma O, Hiroi T, Takaiwa F. Plant Biotechnol J; 2013 Jan 01; 11(1):66-76. PubMed ID: 23066780 [Abstract] [Full Text] [Related]
17. Expression of recombinant T-cell epitopes of major Japanese cedar pollen allergens fused with cholera toxin B subunit in Escherichia coli. Hoang VV, Zou Y, Kurata K, Enomoto K. Protein Expr Purif; 2015 May 01; 109():62-9. PubMed ID: 25665505 [Abstract] [Full Text] [Related]
18. 26-Week oral safety study in macaques for transgenic rice containing major human T-cell epitope peptides from Japanese cedar pollen allergens. Domon E, Takagi H, Hirose S, Sugita K, Kasahara S, Ebinuma H, Takaiwa F. J Agric Food Chem; 2009 Jun 24; 57(12):5633-8. PubMed ID: 19462978 [Abstract] [Full Text] [Related]
19. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level. Sone T, Dairiki K, Morikubo K, Shimizu K, Tsunoo H, Mori T, Kino K. Clin Exp Allergy; 2005 May 24; 35(5):664-71. PubMed ID: 15898991 [Abstract] [Full Text] [Related]
20. Biological assay using T cell response for Cry-consensus peptide designed for the peptide-based immunotherapy of Japanese cedar pollinosis. Kozutsumi D, Tsunematsu M, Yamaji T, Kino K. J Pharmacol Toxicol Methods; 2007 May 24; 55(3):297-302. PubMed ID: 16996752 [Abstract] [Full Text] [Related] Page: [Next] [New Search]